Aptose Biosciences (TSE:APS) Share Price Passes Below 200-Day Moving Average – What’s Next?

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$10.66 and traded as low as C$4.98. Aptose Biosciences shares last traded at C$4.98, with a volume of 1,087 shares changing hands.

Analyst Ratings Changes

Separately, Alliance Global Partners raised Aptose Biosciences to a “strong-buy” rating in a research report on Thursday, February 27th.

Aptose Biosciences Stock Performance

The firm has a market cap of C$214.43 million, a price-to-earnings ratio of -0.99 and a beta of 1.36. The stock’s fifty day moving average is C$6.77 and its two-hundred day moving average is C$10.66. The company has a debt-to-equity ratio of -117.37, a quick ratio of 5.41 and a current ratio of 1.05.

About Aptose Biosciences

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.